EICAR (antiviral)
Overview of EICAR as an antiviral agent
Introduction
EICAR (5-ethynyl-1-_-D-ribofuranosylimidazole-4-carboxamide) is a synthetic compound that has been studied for its potential antiviral properties. It is primarily known for its activity against a range of RNA viruses.
Chemical Structure and Properties
EICAR is a nucleoside analog, which means it mimics the structure of natural nucleosides, the building blocks of nucleic acids. The chemical structure of EICAR includes an ethynyl group attached to the imidazole ring, which is believed to contribute to its antiviral activity.
Mechanism of Action
EICAR functions by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH). This enzyme is crucial for the synthesis of guanosine triphosphate (GTP), a nucleotide necessary for RNA synthesis. By inhibiting IMPDH, EICAR effectively reduces the availability of GTP, thereby hindering viral replication.
Antiviral Activity
EICAR has demonstrated activity against several RNA viruses, including members of the Picornaviridae and Flaviviridae families. Its broad-spectrum antiviral activity makes it a candidate for further research in the development of antiviral therapies.
Potential Applications
The potential applications of EICAR extend to the treatment of viral infections such as those caused by hepatitis C virus (HCV) and rhinovirus. However, its clinical use is limited by its toxicity and the availability of more effective antiviral agents.
Research and Development
Research into EICAR has primarily focused on its mechanism of action and its potential as a lead compound for the development of new antiviral drugs. Studies continue to explore modifications to its structure to enhance its efficacy and reduce toxicity.
Conclusion
While EICAR itself is not used clinically, its study has provided valuable insights into antiviral drug development and the role of nucleoside analogs in inhibiting viral replication.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD